These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19246476)

  • 1. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study.
    Alves G; Müller B; Herlofson K; HogenEsch I; Telstad W; Aarsland D; Tysnes OB; Larsen JP;
    J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):851-7. PubMed ID: 19246476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term risk of falls in an incident Parkinson's disease cohort: the Norwegian ParkWest study.
    Hiorth YH; Alves G; Larsen JP; Schulz J; Tysnes OB; Pedersen KF
    J Neurol; 2017 Feb; 264(2):364-372. PubMed ID: 28000003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in northeast Scotland: the PINE study.
    Caslake R; Taylor K; Scott N; Gordon J; Harris C; Wilde K; Murray A; Counsell C
    Parkinsonism Relat Disord; 2013 May; 19(5):515-21. PubMed ID: 23462482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and course of motor complications in a population-based incident Parkinson's disease cohort.
    Bjornestad A; Forsaa EB; Pedersen KF; Tysnes OB; Larsen JP; Alves G
    Parkinsonism Relat Disord; 2016 Jan; 22():48-53. PubMed ID: 26585090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study.
    Winter Y; Bezdolnyy Y; Katunina E; Avakjan G; Reese JP; Klotsche J; Oertel WH; Dodel R; Gusev E
    Mov Disord; 2010 Feb; 25(3):349-56. PubMed ID: 20108378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue in early Parkinson's disease. Minor inconvenience or major distress?
    Herlofson K; Ongre SO; Enger LK; Tysnes OB; Larsen JP
    Eur J Neurol; 2012 Jul; 19(7):963-8. PubMed ID: 22340430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of Parkinson's disease in the county of Rogaland, Norway.
    Tandberg E; Larsen JP; Nessler EG; Riise T; Aarli JA
    Mov Disord; 1995 Sep; 10(5):541-9. PubMed ID: 8552103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of depressive symptoms in patients with incident Parkinson's disease: a prospective cohort study.
    Larsen JP; Dalen I; Pedersen KF; Tysnes OB
    J Neurol; 2017 Dec; 264(12):2401-2408. PubMed ID: 29032408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of APOE alleles in incident Parkinson's disease. The Norwegian ParkWest Study.
    Vefring H; Haugarvoll K; Tysnes OB; Larsen JP; Kurz MW;
    Acta Neurol Scand; 2010 Dec; 122(6):438-41. PubMed ID: 20456244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson disease: associated disorders in the Norwegian population based incident ParkWest study.
    Skeie GO; Muller B; Haugarvoll K; Larsen JP; Tysnes OB
    Parkinsonism Relat Disord; 2013 Jan; 19(1):53-5. PubMed ID: 22841686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study.
    Pedersen KF; Alves G; Brønnick K; Aarsland D; Tysnes OB; Larsen JP
    J Neurol; 2010 Feb; 257(2):217-23. PubMed ID: 19705051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in Parkinson's disease.
    Haaxma CA; Bloem BR; Borm GF; Oyen WJ; Leenders KL; Eshuis S; Booij J; Dluzen DE; Horstink MW
    J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):819-24. PubMed ID: 17098842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of Parkinson's disease in the North-East of England.
    Duncan GW; Khoo TK; Coleman SY; Brayne C; Yarnall AJ; O'Brien JT; Barker RA; Burn DJ
    Age Ageing; 2014 Mar; 43(2):257-63. PubMed ID: 23880142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial aggregation of Parkinson's disease may affect progression of motor symptoms and dementia.
    Gaare JJ; Skeie GO; Tzoulis C; Larsen JP; Tysnes OB
    Mov Disord; 2017 Feb; 32(2):241-245. PubMed ID: 27862270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.
    Linder J; Stenlund H; Forsgren L
    Mov Disord; 2010 Feb; 25(3):341-8. PubMed ID: 20108376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time Trends in the Incidence of Parkinson Disease.
    Savica R; Grossardt BR; Bower JH; Ahlskog JE; Rocca WA
    JAMA Neurol; 2016 Aug; 73(8):981-9. PubMed ID: 27323276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria.
    Okubadejo NU; Ojo OO; Oshinaike OO
    BMC Neurol; 2010 Jan; 10():1. PubMed ID: 20051133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of prognostic survival models in newly diagnosed Parkinson's disease.
    Macleod AD; Dalen I; Tysnes OB; Larsen JP; Counsell CE
    Mov Disord; 2018 Jan; 33(1):108-116. PubMed ID: 28976022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.